Condensed Statements of Cash Flows - USD ($)		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Cash Flows From Operating Activities
Net loss		$ (5,450,910)	$ (5,932,384)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		28,229	2,553
Stock-based compensation		583,865	1,032,960
Changes in operating assets and liabilities:
Prepaid expenses and other current assets		(189,021)	(427,573)
Accounts payable		(288,600)	551,519
Accrued compensation		(568,864)	(495,043)
Accrued expenses and other current liabilities		(32,623)	(630,388)
Deferred rent		(3)	1,616
Net Cash Used In Operating Activities		(5,917,927)	(5,896,740)
Cash Flows From Investing Activities
Purchases of property and equipment		(93,930)	0
Net Cash Used In Investing Activities		(93,930)	0
Cash Flows From Financing Activities
Proceeds from sale of units in private placement	[1]	5,569,136	0
Repayment of short-term note payable		(52,051)	0
Payment of private placement issuance costs		(1,738)	0
Proceeds from exercise of stock options		0	483,888
Net Cash Provided By Financing Activities		5,515,347	483,888
Net Decrease in Cash		(496,510)	(5,412,852)
Cash - Beginning of Period		14,152,601	19,728,200
Cash - End of Period		13,656,091	14,315,348
Supplemental Disclosure of Cash Flow Information:
Interest expense		1,699	0
Income taxes		0	0
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Accrual of private placement offering costs		115,656	0
Purchase of insurance premium financed by short-term note payable		475,216	0
Exercise of warrants on a cashless basis		$ 0	$ 24

[1] Includes gross proceeds of $5,984,931, less issuance costs of $415,795 deducted directly from the offering proceeds.